STAT+: Alnylam sues Pfizer and Moderna for patent infringement in development of Covid-19 vaccines

Alnylam Pharmaceuticals has filed separate lawsuits alleging that Pfizer and Moderna infringed its patents in developing their Covid-19 vaccines, the latest dispute over valuable intellectual property stemming from the pandemic.

In each suit, Alnylam claims the companies used its lipid nanoparticles technology that carries and delivers RNA-based therapies or vaccines in the body. RNA plays a key role in turning the instructions held in the DNA of a person’s genome into functional proteins in cells. Both Pfizer and Moderna developed and now market mRNA-based vaccines, and mRNA is a type of RNA.

Continue to STAT+ to read the full story…

Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.